Long COVID Trial, Recruiting (NCT06932237)

Long COVID Trial, Recruiting NCT06932237 Sponsor: VA Office of Research and Development Condition: Long COVID

Printed from Voxsanity (voxsanity.com.au) — NCT06932237 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Long Covid

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You had a confirmed COVID-19 infection at least 4 weeks before signing up, shown by a positive PCR test or a positive home antigen test
You are able to give informed consent, meaning you understand what the study involves and can agree to take part voluntarily (checked through a brief assessment)
(For one specific group in the trial only) You are currently experiencing neurological or cognitive symptoms (such as brain fog or memory problems) that started after your COVID-19 infection, confirmed through a 46-question symptom survey

Who may not be able to join:

You were diagnosed with dementia, a traumatic brain injury, Parkinson's disease, Alzheimer's disease, or another condition affecting the brain or thinking before your COVID-19 infection
You were diagnosed with a mood disorder or psychotic disorder (such as depression, bipolar disorder, or schizophrenia) before your COVID-19 infection
You had fibromyalgia or chronic fatigue syndrome before your COVID-19 infection
You currently have an unstable medical condition, or an autoimmune or inflammatory condition that is not well controlled

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jennifer M Loftis, MA PhD, VA Portland Health Care System, Portland, OR

Phone: (503) 220-8262

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06932237

Sponsor: VA Office of Research and Development

Phase: Not Applicable

Status: Recruiting

Condition: Long COVID

Trial contact: (503) 220-8262

More information: https://clinicaltrials.gov/study/NCT06932237

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You had a confirmed COVID-19 infection at least 4 weeks before signing up, shown by a positive PCR test or a positive home antigen test
You are able to give informed consent, meaning you understand what the study involves and can agree to take part voluntarily (checked through a brief assessment)
(For one specific group in the trial only) You are currently experiencing neurological or cognitive symptoms (such as brain fog or memory problems) that started after your COVID-19 infection, confirmed through a 46-question symptom survey

Who may not be able to join:

You were diagnosed with dementia, a traumatic brain injury, Parkinson's disease, Alzheimer's disease, or another condition affecting the brain or thinking before your COVID-19 infection
You were diagnosed with a mood disorder or psychotic disorder (such as depression, bipolar disorder, or schizophrenia) before your COVID-19 infection
You had fibromyalgia or chronic fatigue syndrome before your COVID-19 infection
You currently have an unstable medical condition, or an autoimmune or inflammatory condition that is not well controlled

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

VA Office of Research and Development

Registry

ClinicalTrials.gov

Start date

20 February 2025

Est. completion

31 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Fatigue Severity Scale (FSS); Prospective and Retrospective Memory Questionnaire (PRMQ); Spatial Working Memory (SWM); Paired Associates Learning (PAL); Stockings of Cambridge (SOC); Delayed Matching Sample (DMS); Rapid Visual Information Processing (RVP); Apolipoprotein E (APOE) Genotyping; Long Covid Questionnaire; Delis-Kaplan Executive Functioning - Verbal Fluency (D-KEFS-VF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov